Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 6 studies | 45% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 99% | 11611.12 | 88 / 89 | 51% | 53.74 | 463 / 901 |
brain | 90% | 182.06 | 2385 / 2642 | 59% | 5.57 | 414 / 705 |
eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
esophagus | 0% | 0.05 | 2 / 1445 | 1% | 0.01 | 1 / 183 |
adipose | 1% | 0.42 | 8 / 1204 | 0% | 0 | 0 / 0 |
breast | 1% | 0.39 | 3 / 459 | 0% | 0 | 0 / 1118 |
skin | 0% | 0.06 | 2 / 1809 | 0% | 0.03 | 2 / 472 |
liver | 0% | 0 | 0 / 226 | 0% | 0.02 | 2 / 406 |
prostate | 0% | 0.16 | 1 / 245 | 0% | 0 | 0 / 502 |
adrenal gland | 0% | 0.15 | 1 / 258 | 0% | 0 | 0 / 230 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.02 | 1 / 430 |
intestine | 0% | 0.05 | 2 / 966 | 0% | 0 | 0 / 527 |
thymus | 0% | 0.03 | 1 / 653 | 0% | 0 | 0 / 605 |
lung | 0% | 0 | 0 / 578 | 0% | 0.00 | 1 / 1155 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 0% | 0 | 0 / 286 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
uterus | 0% | 0 | 0 / 170 | 0% | 0 | 0 / 459 |
GO_0055085 | Biological process | transmembrane transport |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0072237 | Biological process | metanephric proximal tubule development |
GO_0097254 | Biological process | renal tubular secretion |
GO_0042908 | Biological process | xenobiotic transport |
GO_0006820 | Biological process | monoatomic anion transport |
GO_0015732 | Biological process | prostaglandin transport |
GO_0015742 | Biological process | alpha-ketoglutarate transport |
GO_0015711 | Biological process | organic anion transport |
GO_0043252 | Biological process | sodium-independent organic anion transport |
GO_0015698 | Biological process | inorganic anion transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0005901 | Cellular component | caveola |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
GO_0031404 | Molecular function | chloride ion binding |
GO_0015297 | Molecular function | antiporter activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0042910 | Molecular function | xenobiotic transmembrane transporter activity |
GO_0015347 | Molecular function | sodium-independent organic anion transmembrane transporter activity |
GO_0015139 | Molecular function | alpha-ketoglutarate transmembrane transporter activity |
GO_0015132 | Molecular function | prostaglandin transmembrane transporter activity |
GO_0005452 | Molecular function | solute:inorganic anion antiporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0022857 | Molecular function | transmembrane transporter activity |
Gene name | SLC22A6 |
Protein name | Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1) Solute carrier family 22 member 6 |
Synonyms | OAT1 PAHT |
Description | FUNCTION: Secondary active transporter that functions as a Na(+)-independent organic anion (OA)/dicarboxylate antiporter where the uptake of one molecule of OA into the cell is coupled with an efflux of one molecule of intracellular dicarboxylate such as 2-oxoglutarate or glutarate . Mediates the uptake of OA across the basolateral side of proximal tubule epithelial cells, thereby contributing to the renal elimination of endogenous OA from the systemic circulation into the urine . Functions as a biopterin transporters involved in the uptake and the secretion of coenzymes tetrahydrobiopterin (BH4), dihydrobiopterin (BH2) and sepiapterin to urine, thereby determining baseline levels of blood biopterins . Transports prostaglandin E2 (PGE2) and prostaglandin F2-alpha (PGF2-alpha) and may contribute to their renal excretion . Also mediates the uptake of cyclic nucleotides such as cAMP and cGMP . Involved in the transport of neuroactive tryptophan metabolites kynurenate (KYNA) and xanthurenate (XA) and may contribute to their secretion from the brain . May transport glutamate . Also involved in the disposition of uremic toxins and potentially toxic xenobiotics by the renal organic anion secretory pathway, helping reduce their undesired toxicological effects on the body . Uremic toxins include the indoxyl sulfate (IS), hippurate/N-benzoylglycine (HA), indole acetate (IA), 3-carboxy-4- methyl-5-propyl-2-furanpropionate (CMPF) and urate . Xenobiotics include the mycotoxin ochratoxin (OTA) . May also contribute to the transport of organic compounds in testes across the blood-testis-barrier . . |
Accessions | ENST00000540654.5 Q4U2R8 ENST00000458333.6 [Q4U2R8-3] ENST00000377871.7 [Q4U2R8-1] F5H0T7 ENST00000421062.2 [Q4U2R8-4] ENST00000360421.9 [Q4U2R8-2] |